Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Long-term safety of topical pimecrolimus and topical tacrolimus in atopic blepharoconjunctivitis.

Kiiski V, Remitz A, Reitamo S, Mandelin J, Kari O.

JAMA Dermatol. 2014 May;150(5):571-3. No abstract available.

PMID:
24500107
2.

Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure.

Remitz A, Virtanen HM, Reitamo S, Kari O.

Acta Ophthalmol. 2011 May;89(3):e295-6. doi: 10.1111/j.1755-3768.2009.01834.x. No abstract available.

3.
4.

Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.

Sakarya Y, Sakarya R.

J Ocul Pharmacol Ther. 2012 Feb;28(1):94-6. doi: 10.1089/jop.2011.0143.

PMID:
22103968
5.

Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.

Joseph MA, Kaufman HE, Insler M.

Cornea. 2005 May;24(4):417-20.

PMID:
15829797
6.

[FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients].

Mayer K, Reinhard T, Reis A, Böhringer D, Sundmacher R.

Klin Monbl Augenheilkd. 2001 Nov;218(11):733-6. German.

PMID:
11731901
7.

Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis.

Van Leent EJ, Ebelin ME, Burtin P, Dorobek B, Spuls PI, Bos JD.

Dermatology. 2002;204(1):63-8.

PMID:
11834853
8.

[Treatment of eye allergies].

Kari O, Saari KM.

Duodecim. 2012;128(3):291-7. Review. Finnish.

PMID:
22428383
9.
10.
11.

Pimecrolimus: a review.

Gupta AK, Chow M.

J Eur Acad Dermatol Venereol. 2003 Sep;17(5):493-503. Review.

PMID:
12941081
12.

Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.

Tzu JH, Utine CA, Stern ME, Akpek EK.

Cornea. 2012 Jun;31(6):649-54. doi: 10.1097/ICO.0b013e31822481c2.

PMID:
22378107
13.

Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.

Cheng AC, Yuen K, Chan W.

Cornea. 2006 Jun;25(5):634; author reply 634. No abstract available.

PMID:
16783160
14.

Association between exposure to topical tacrolimus or pimecrolimus and cancers.

Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.

Ann Pharmacother. 2009 Dec;43(12):1956-63. doi: 10.1345/aph.1M278.

PMID:
19903860
15.

Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis.

Wan XC, Dimov V.

Expert Opin Drug Metab Toxicol. 2014 Apr;10(4):543-9. doi: 10.1517/17425255.2014.884070. Review.

PMID:
24490943
16.

Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial.

Kaufmann R, Bieber T, Helgesen AL, Andersen BL, Luger T, Poulin Y, Al-Hafidh J, Paul C; multicentre investigator group..

Allergy. 2006 Mar;61(3):375-81.

17.

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Hultsch T, Kapp A, Spergel J.

Dermatology. 2005;211(2):174-87. Review. Erratum in: Dermatology. 2005;211(3):292.

18.

Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis.

Meurer M, Fartasch M, Albrecht G, Vogt T, Worm M, Ruzicka T, Altmeyer PJ, Schneider D, Weidinger G, Braeutigam M; CASM-DE-01 Study Group..

Dermatology. 2004;208(4):365-72.

PMID:
15178928
19.

Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.

Chen SL, Yan J, Wang FS.

J Dermatolog Treat. 2010 May;21(3):144-56. doi: 10.3109/09546630903401470. Review.

PMID:
20394490
20.

Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.

Meurer M, Eichenfield LF, Ho V, Potter PC, Werfel T, Hultsch T.

J Dermatolog Treat. 2010 May;21(3):157-66. doi: 10.3109/09546630903410158.

PMID:
20394491
Items per page

Supplemental Content

Support Center